Eli Lilly has named Thomas Fuchs as its first-ever chief artificial intelligence officer (CAIO), bolstering the digital ...

The way forward, then, is to deliver truly personalised medicines and care. For industry, this means developing therapies ...

Another interesting finding was that the preference for hybrid meetings almost doubled between 2022 and 2023, while the ...

Zealand Pharma has suffered another setback in its bid to bring glucagon receptor agonist dasiglucagon for ultra-rare disease ...

Closed Loop Medicine is a TechBio company developing prescription combination drug plus software products, with the aim of ...

Sage Therapeutics has said it will stop the development of dalzanemdor in Alzheimer's disease, a few months after pulling the ...

Takeda's recently approved advanced colorectal cancer therapy Fruzaqla has been rejected by NICE for use by the NHS on the ...

The FDA approved Zurzuvae as the first oral therapy for post-partum depression (PPD) in August 2023, although, the agency ...

The right partners excel at delivering precise, targeted messages to the right audience segments. This requires deep understanding of the nuances of the healthcare environment and the right skills to ...

UK Health Secretary Wes Streeting has announced plans to allow NHS England to share primary care data with scientific ...

A partnership between AI specialist Owkin and drugmaker AstraZeneca has been formed to find tools that can be applied to ...

The figures show that ADHD medicine prescriptions have seen the steepest rise, particularly since 2020/21. Last year, 278,000 ...